• Home
• prostate cancer treatment
• advanced prostate cancer
• lung cancer treatment
• small cell lung cancer

prostate cancer therapy

'Business in the Burbs': Bunge merger falls through (The Journal News)
Increasing numbers of mergers and acquisitions are falling apart as the global financial crisis, volatile stock market and economic slowdown alter deal dynamics.

Progenics Reports Third Quarter 2008 Financial Results and Corporate Updates (Centre Daily Times)
Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) today announced its results of operations for the third quarter and nine months ended September 30, 2008.

Get a Deep Insight into the Cancer Therapeutics: Market Insight and R&D Pipeline Analysis (Business Wire via Yahoo! Finance)
NEW YORK----Reportlinker.com announces that a new market research report related to the Pharmaceutical industry industry is available in its catalogue.

Optimized Radiation For Prostate Cancer Therapy (Science Daily)
The determination of the precise anatomical location of a tumor is the prerequisite for setting optimal parameters for radiation treatment of prostate cancer. This approach guarantees that the ionizing radiation only destroys tumorous cells and does not affect other organs in the vicinity of the prostate. In a cooperative study with Innsbruck Medical University and the East-Vienna Center of ...

Next Generation CyberKnife System Cuts Prostate Cancer Treatment Times in Half at CyberKnife Centers of San Diego (PR Newswire via Yahoo! Finance)
Accuray Incorporated , a global leader in the field of radiosurgery, announced today that CyberKnife Centers of San Diego has shortened prostate cancer treatment times, while further improving the quality of treatment plans, by upgrading one of its CyberKnife® Robotic Radiosurgery Systems with the next-generation technology.

Market Insight and R&D Pipeline Analysis for Cancer Therapeutics (Business Wire via Yahoo! Finance)
DUBLIN, Ireland----Research and Markets has announced the addition of the "Cancer Therapeutics - Market Insight and R&D Pipeline Analysis" report to their offering.